Caffeine shows no lasting benefit for preemies with apnea

01/17/2012 | PhysiciansBriefing.com

A five-year study in the Journal of the American Medical Association found that neonatal caffeine treatment for apnea of prematurity did not improve survival without disability. The caffeine group and the placebo group did not differ in terms of mortality rate, behavior problems, motor impairment, poor general health, blindness or deafness, researchers reported.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC